finnCap Reiterates a “Corporate” Rating on Proteome Sciences PLC (LON:PRM) and GBX 7.00 Target; Wheaton Precious Metals (WPM) Shorts Lowered By 17.1%

Expert analysts at finnCap have GBX 7.00 target price on Proteome Sciences PLC (LON:PRM). finnCap’s target price would suggest a potential upside of 115.38% from the company’s stock close price. The rating was disclosed to clients in an analyst note on Monday morning.

Wheaton Precious Metals Corporation (NYSE:WPM) had a decrease of 17.1% in short interest. WPM’s SI was 8.81M shares in February as released by FINRA. Its down 17.1% from 10.63 million shares previously. With 2.20M avg volume, 4 days are for Wheaton Precious Metals Corporation (NYSE:WPM)’s short sellers to cover WPM’s short positions. The stock decreased 4.18% or $0.83 during the last trading session, reaching $19.02. About 9.52 million shares traded or 267.21% up from the average. Wheaton Precious Metals Corp. (NYSE:WPM) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Wheaton Precious Metals Corp. operates as a silver and gold streaming firm worldwide. The company has market cap of $8.30 billion. It has streaming agreements for 21 operating mines and 8 development stage projects. It has a 41.08 P/E ratio. The firm was formerly known as Silver Wheaton Corp. and changed its name to Wheaton Precious Metals Corp. in May 2017.

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company has market cap of 9.99 million GBP. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. It currently has negative earnings. The firm designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.

The stock increased 3.83% or GBX 0.125 during the last trading session, reaching GBX 3.385. About 29 shares traded. Proteome Sciences plc (LON:PRM) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.